NOT KNOWN DETAILS ABOUT WHO MAKES COPYRIGHT IN USA

U.S. pharma giant copyright scrapped two experimental weight loss tablets last calendar year—a once-day-to-day capsule, lotiglipron, as a result of elevated liver enzymes plus a twice-day-to-day pill, danuglipron, resulting from solid side effects—but CEO Albert Bourla has stated the company is determined to “play and gain” from the weight